These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
676 related items for PubMed ID: 25001020
1. Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia. El Behery MM, Saleh HS, Ibrahiem MA, Kamal EM, Kassem GA, Mohamed Mel S. Reprod Sci; 2015 Mar; 22(3):329-34. PubMed ID: 25001020 [Abstract] [Full Text] [Related]
2. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia. Mittermeier T, Farrant C, Wise MR. Cochrane Database Syst Rev; 2020 Sep 06; 9(9):CD012658. PubMed ID: 32909630 [Abstract] [Full Text] [Related]
3. Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia. Bian J, Shao H, Liu H, Li H, Fang L, Xing C, Wang L, Tao M. Reprod Sci; 2015 Jun 06; 22(6):758-66. PubMed ID: 25536958 [Abstract] [Full Text] [Related]
4. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK. Hum Reprod; 2013 Nov 06; 28(11):2966-71. PubMed ID: 23975691 [Abstract] [Full Text] [Related]
5. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up. Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK. Hum Reprod; 2013 May 06; 28(5):1231-6. PubMed ID: 23466671 [Abstract] [Full Text] [Related]
6. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study. Kim MK, Seong SJ, Kim JW, Jeon S, Choi HS, Lee IH, Lee JH, Ju W, Song ES, Park H, Ryu HS, Lee C, Kang SB. Int J Gynecol Cancer; 2016 May 06; 26(4):711-5. PubMed ID: 26905333 [Abstract] [Full Text] [Related]
7. Oral and intrauterine progestogens for atypical endometrial hyperplasia. Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N. Cochrane Database Syst Rev; 2018 Dec 04; 12(12):CD009458. PubMed ID: 30521671 [Abstract] [Full Text] [Related]
8. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study. Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, Gupta JK. Eur J Obstet Gynecol Reprod Biol; 2008 Aug 04; 139(2):169-75. PubMed ID: 18440693 [Abstract] [Full Text] [Related]
9. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Romero SA, Young K, Hickey M, Su HI. Cochrane Database Syst Rev; 2020 Dec 21; 12(12):CD007245. PubMed ID: 33348436 [Abstract] [Full Text] [Related]
10. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Lethaby AE, Cooke I, Rees M. Cochrane Database Syst Rev; 2005 Oct 19; (4):CD002126. PubMed ID: 16235297 [Abstract] [Full Text] [Related]
11. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Dominick S, Hickey M, Chin J, Su HI. Cochrane Database Syst Rev; 2015 Dec 09; 2015(12):CD007245. PubMed ID: 26649916 [Abstract] [Full Text] [Related]
12. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone. Suvanto-Luukkonen E, Malinen H, Sundström H, Penttinen J, Kauppila A. Acta Obstet Gynecol Scand; 1998 Aug 09; 77(7):758-63. PubMed ID: 9740525 [Abstract] [Full Text] [Related]
13. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Chin J, Konje JC, Hickey M. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007245. PubMed ID: 19821400 [Abstract] [Full Text] [Related]
14. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review. Buttini MJ, Jordan SJ, Webb PM. Aust N Z J Obstet Gynaecol; 2009 Jun 07; 49(3):316-22. PubMed ID: 19566568 [Abstract] [Full Text] [Related]
15. Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia. Ismail MT, Fahmy DM, Elshmaa NS. Reprod Sci; 2013 Jan 07; 20(1):45-50. PubMed ID: 23203322 [Abstract] [Full Text] [Related]
16. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia. Haoula ZJ, Walker KF, Powell MC. Eur J Obstet Gynecol Reprod Biol; 2011 Nov 07; 159(1):176-9. PubMed ID: 21741152 [Abstract] [Full Text] [Related]
17. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system. Sturridge F, Guillebaud J. Drug Saf; 1996 Dec 07; 15(6):430-40. PubMed ID: 8968696 [Abstract] [Full Text] [Related]
18. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia<sup/>. Marnach ML, Butler KA, Henry MR, Hutz CE, Langstraat CL, Lohse CM, Casey PM. J Womens Health (Larchmt); 2017 Apr 07; 26(4):368-373. PubMed ID: 27901412 [Abstract] [Full Text] [Related]
19. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF. Hum Reprod; 1998 May 07; 13(5):1210-7. PubMed ID: 9647549 [Abstract] [Full Text] [Related]
20. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials. Abu Hashim H, Ghayaty E, El Rakhawy M. Am J Obstet Gynecol; 2015 Oct 07; 213(4):469-78. PubMed ID: 25797236 [Abstract] [Full Text] [Related] Page: [Next] [New Search]